Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone

Intermediate Osteoclastic Giant Cell-Rich Tumor of Bone — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03295981	Local Bisphosphonate Effect on Recurrence Rate in Extremity Giant Cell Tumor of Bone	recruiting	Phase 3	120	St. Louis UniversityOTHER	3	Apr 22, 2026	clinicaltrials
NCT05813665	A Study to Evaluate the Efficacy and Safety of Narlumosbart (JMT103) in Patients With Giant Cell Tumor of Bone	not yet recruiting	Phase 3	146	Shanghai JMT-Bio Inc.INDUSTRY	1	Apr 19, 2023	clinicaltrials